MICHELLE JONES: Open Payments
NPI 1235508920 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 66 payments from 16 companies in 2025. Trend: 2023 $757 · 2024 $1,093 · 2025 $1,799
Food & beverage: $1,799
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $369 |
| Novo Nordisk Inc | 11 | $294 |
| PFIZER INC. | 5 | $198 |
| Amgen Inc. | 5 | $197 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $131 |
| GlaxoSmithKline, LLC. | 7 | $125 |
| ABBVIE INC. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $47 |
Products named: FARXIGA, Wegovy, Kerendia, NURTEC ODT, JARDIANCE, EVENITY, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
